Cloxacillin levels during continuous infusion
Part of Infections clinical trials.
This trial measures how the body processes cloxacillin when it's given as a continuous infusion for infections. If you're already receiving this treatment, the results may help doctors optimize your dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor has decided to start a continuous infusion of cloxacillin
- You are willing and able to give written permission to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two ways of giving the antibiotic ceftazidime/avibactam (a powerful drug for resistant bacteria) to critically ill patients in the ICU. The goal is to see if a continuous infusion works better than standard timed doses.
This Phase 2 study tests whether continuous IV antibiotics plus “drug level monitoring” (TDM) works better than the usual treatment for complicated Staph aureus infections. It may help ensure the antibiotic dose stays in an effective range while you’re being treated.
This study tests whether children can safely receive antibiotics continuously through a pump at home instead of in the hospital. The goal is to help children recover while staying with their family and avoiding prolonged hospital stays.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
This study measures how much of the antibiotic delafloxacin gets into skin, soft tissue, and bone in people with serious infections. It may help doctors understand if the drug reaches the infection site well enough to be effective.
Hear when a new Staphylococcal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.